Reuters logo
BRIEF-Steadymed completes clinical validation study of trevyent
April 5, 2017 / 1:28 PM / 8 months ago

BRIEF-Steadymed completes clinical validation study of trevyent

April 5 (Reuters) - Steadymed Ltd

* Steadymed completes clinical validation study of trevyent

* Steadymed Ltd says remains on track for a new drug application submission for trevyent to treat PAH, in Q2 of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below